Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Sulfonamides designed at Banyu which act as ORL1 antagonists

May 25, 2001

Almirall Prodesfarma granted exclusive rights to Japanese antipsychotic

May 25, 2001

New serotonergic agents from BASF covered by U.S. patent

May 24, 2001

Ergoline derivatives synthesized at Novartis useful in depression, anxiety, etc.

May 24, 2001

Sepracor seeks FDA approval to evaluate new anxiolytic in humans

May 24, 2001

Tachykinin antagonists described in recent patent by Glaxo

May 23, 2001

Liver-sparing effect described for NO derivative of acetaminophen at Digestive Disease Week

May 23, 2001

Two patents issued for Lilly's new serotonergic piperidine derivatives

May 22, 2001

Synthesis and use of azepinoindole PARP inhibitors in neurodegenerative disorders

May 22, 2001

Potential antidepressants in the GSK pipeline

May 22, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...